TiCARos’ Converter platform uses a chimeric CTLA4 mutant composed of an extracellular CTLA4 domain and an intracellular cluster of differentiation 28 (CD28) domain (a CTLA4–CD28 chimera).
Some results have been hidden because they may be inaccessible to you